Ovarian function in Duarte galactosemia
- PMID: 21719007
- PMCID: PMC3773175
- DOI: 10.1016/j.fertnstert.2011.05.088
Ovarian function in Duarte galactosemia
Abstract
Objective: To determine if girls with Duarte variant galactosemia (DG) have an increased risk of developing premature ovarian insufficiency based on prepubertal anti-Müllerian hormone (AMH) levels.
Design: Cross-sectional study.
Setting: University research laboratory.
Patient(s): Study volunteers included 57 girls with DG, 89 girls with classic galactosemia (GG), and 64 control girls between the ages of <1 month and 10.5 years.
Intervention(s): Blood sampling.
Main outcome measure(s): We determined AMH and FSH levels in study volunteers with and without Duarte variant or GG.
Result(s): FSH levels were significantly higher and AMH levels significantly lower in girls with GG than in age-stratified control girls, but there was no significant difference between FSH and AMH levels in girls with DG and control girls.
Conclusion(s): Although >80% of girls with GG in this study demonstrated low to undetectable AMH levels consistent with diminished ovarian reserve, 100% of girls with DG in our study demonstrated no apparent decrease in AMH levels or increase in FSH levels, suggesting that these girls are not at increased risk for premature ovarian insufficiency.
Copyright © 2011. Published by Elsevier Inc.
Conflict of interest statement
J.R.B. has nothing to disclose. U.C. has nothing to disclose. T.J.G. has nothing to disclose. J.B.S. has nothing to disclose. M.P.E. has nothing to disclose. C.F. has nothing to disclose. K.F. has nothing to disclose. J.L.F-K. has nothing to disclose.
Figures
References
-
- Fridovich-Keil J, Walter J. Galactosemia. In: Valle D, Beaudet A, Vogelstein B, Kinzler K, Antonarakis S, Ballabio A, editors. The Online Metabolic and Molecular Bases of Inherited Disease—OMMBID. New York: McGraw-Hill; 2008. www.ommbid.com.
-
- Fernhoff PM. Duarte galactosemia: how sweet is it? Clin Chem. 2010;56:1045–6. - PubMed
-
- Ficicioglu C, Hussa C, Gallagher PR, Thomas N, Yager C. Monitoring of biochemical status in children with Duarte galactosemia: utility of galactose, galactitol, galactonate, and galactose 1-phosphate. Clin Chem. 2010;56:1177–82. - PubMed
-
- Ficicioglu C, Thomas N, Yager C, Gallagher PR, Hussa C, Mattie A, et al. Duarte (DG) galactosemia: a pilot study of biochemical and neurodevelopmental assessment in children detected by newborn screening. Mol Genet Metab. 2008;95:206–12. - PubMed
-
- Powell KK, van Naarden Braun K, Singh RH, Shapira SK, Olney RS, Yeargin-Allsopp M. Long-term speech and language developmental issues among children with Duarte galactosemia. Genet Med. 2009;11:874–9. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
